Trial intelligence / Profile preview

High-dose versus low-dose captopril in congestive heart failure with left-to-right shunt

IRCT2012072910441N1Phase 2Completed

Sponsor
Shiraz University of Medical Sciences
Start
Sep 2011
Modality
Small Molecules
Countries
1
01

Overview

Phase 2 trial of captopril in heart failure (HF) and Cardiovascular Malformation (CVM) (2 arms), sponsored by Shiraz University of Medical Sciences. Started Sep 2011; status: completed.

02

Drugs

captopril
03

Conditions

heart failure (HF)Cardiovascular Malformation (CVM)

Beyond the preview

Go deeper on IRCT2012072910441N1.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on IRCT2012072910441N1.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call